0001628280-21-015647.txt : 20210804 0001628280-21-015647.hdr.sgml : 20210804 20210804200130 ACCESSION NUMBER: 0001628280-21-015647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210804 DATE AS OF CHANGE: 20210804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy Matthew B. CENTRAL INDEX KEY: 0001865778 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 211145810 MAIL ADDRESS: STREET 1: C/O NAUTILUS BIOTECHNOLOGY, INC. STREET 2: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wf-form4_162812167372819.xml FORM 4 X0306 4 2021-06-14 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001865778 Murphy Matthew B. C/O NAUTILUS BIOTECHNOLOGY, INC. 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 0 1 0 0 General Counsel Stock Option (Right to Buy) 10.1 2021-06-14 4 A 0 326526 0 A 2031-06-14 Common Stock 326526.0 326526 D Subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan), 25% of the shares subject to such Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date (as defined below), and the balance of the shares subject to such Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary. The Vesting Commencement Date is April 1, 2021. /s/ Matthew B. Murphy 2021-08-04